New psychoactive substances - A contemporary challenge for forensic toxicologists;Nowe substancje psychoaktywne - Wspólczesne wyzwanie dla toksykologów sadowych

Z Zagadnien Nauk Sadowych

Volumn 100, Issue , 2014, Pages 359-385

  Zuba, Dariusz ^a  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

Cannabinoids; Cathinones; Legal highs; Legislation; Phenethylamines; Tryptamines

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (1,3 BENZODIOXOL 5 YL) 2 (PYRROLIDIN 1 YL)PENTAN 1 ONE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 1 (4 FLUOROPHENYL)PIPERAZINE; 1 (4 METHOXYPHENYL)PIPERAZINE; 1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1 BUTYL 3 (1 NAPHTHOYL)INDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 METHYLMETHCATHINONE; 4 METHYL N ETHYLCATHINONE; 4' METHYLMETHCATHINONE; AMPHETAMINE; CAFFEINE; CANNABINOID DERIVATIVE; CANNABIS; CATHINONE; CONTROLLED SUBSTANCE; DEXANABINOL; FENFLURAMINE; GLAUCINE; HERBACEOUS AGENT; LIDOCAINE; MANGANESE DERIVATIVE; METHYLPHENIDATE; METOCLOPRAMIDE; MEXILETINE; PHENCYCLIDINE; PIPERAZINE DERIVATIVE; PSYCHOTROPIC AGENT; THEOBROMINE; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOGRAPHY; DRUG DEPENDENCE; DRUG INTOXICATION; DRUG LEGISLATION; DRUG MARKETING; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERNET; LAW; LAW ENFORCEMENT; MASS SPECTROMETRY; MICROCAPSULE; MITRAGYNA; POLAND; POWDER; PSYCHOACTIVE PLANT; SALVIA; SALVIA DIVINORUM; TABLET;

EID: 84945588530     PISSN: 12307483     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. adamowicz, P., Tokarczyk, b., Stanaszek, R., Slopianka, M. (2013). Fatal mephedrone intoxication - a case report. Journal of Analytical Toxicology, 37(1), 37-42.
2. Adamowicz P., Zuba, D., Sekula, K. (2013). Analysis of uR-144 and its pyrolysis product in blood and their metabolites in urine. Forensic Science International, 233, 320-327.
3. auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., Ferreirós, N. (2009). "Spice" and other herbal blends: Harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44, 832-837.
4. aung, M. M., Griffin, G., Huffman, J. W., Wu, M. J., Keel, C., Yang, b., Showalter, V. M., abood, M. E., Martin, b. R. (2000). Influence of the N-1 alkyl chain length of cannabimimetic indoles upon Cb1 and Cb2 receptor binding. Drug and Alcohol Dependence, 60(2), 133-140.
5. baron, M., Elie, M., Elie, L. (2011) an analysis of legal highs: do they contain what it says on the tin? Drug Testing and Analysis, 3, 576-581.
6. bell, L. N., Wetzel, C. R., Grand, a. N. (1996). Caffeine content in coffee as influenced by grinding and brewing techniques. Food Research International, 29, 785-789.
7. brandt, S. D., Freeman, S., Sumnall, H. R., Measham, F., Cole, J. (2011). analysis of NRG "legal highs" in the uK: identification and formation of novel cathinones. Drug Testing and Analysis, 3, 569-575.
8. brandt, S. D., Sumnall, H. R., Measham, F., Cole, J. (2010). analyses of second- generation "legal highs" in the uK: Initial findings. Drug Testing and Analysis, 2, 377-382.
9. Cohen, b. M. Z., butler, R. (2011). bZP-party pills: A review of research on benzylpiperazine as a recreational drug. International Journal of Drug Policy, 22(2), 95-101.
10. Davies, S., Wood, D. M., Smith, G., button, J., Ramsey, J., archer, R., Holt, D. W., Dargan, P. I. (2010). Purchasing "legal highs" on the Internet - Is there consistency in what you get? Quarterly Journal of Medicine, 103, 489-493.
11. Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., auwärter, V. (2010). Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. Journal of Mass Spectrometry, 45, 1186-1194.
12. European Monitoring Centre for Drugs and Drugs addiction. (2005). Europol -EMCDDA Joint report on a new psychoactive substance: 1( 3chlorophenyl) piperazine (mCPP). (Website) http://www.emcdda.europa.eu/html. cfm/index132212EN.html
13. European Monitoring Centre for Drugs and Drugs addiction. (2006). Hallucinogenic mushrooms. An emerging trend case study. (Website) http://www.emcdda.europa. eu/publications/thematic-papers/mushrooms
14. European Monitoring Centre for Drugs and Drugs addiction. (2009a). Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. (Website) http://www.emcdda.europa. eu/publications/risk-assessments/bzp
15. European Monitoring Centre for Drugs and Drugs addiction. (2009b). Understanding the Spice phenomenon. (Website) http://www.emcdda.europa.eu/publications/ thematic-papers/spice
16. European Monitoring Centre for Drugs and Drugs addiction. (2014). European drug report 2014: Trends and developments. (Website) www.emcdda.europa.eu/publications/ edr/trends-developments/2014.
17. Gurney, S. M. R., Scott K. S., Kacinko, S. L., Presley, b. C., Logan, b. K. (2014). Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs, Forensic Science Review, 1, 26-53.
18. Henderson, G. L. (1988) Designer drugs: Past history and future prospects, Journal of Forensic Sciences, 33, 569-575.
19. Hillebrand, J., Olszewski, D., Sedefov, R. (2010). Legal highs on the Internet, Substance Use & Misuse, 45, 330-340.
20. Huffman, J. W., Szklennik, P. V., almond, a., bushell, K., Selley, D. E., He, H. (2005). 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorganic and Medical Chemistry Letters, 15, 4110-4113.
21. Huffman, J. W. (2009). Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. (In) P. H. Reggio (ed.), The cannabinoid receptors (pp. 70-92). Totowa: Humana Press.
22. James, D., adams, R. D., Spears, R., Cooper, G., Lupton, D. J., Thompson, J. P. Thomas, S. H. L. (2011). Clinical characteristics of mephedrone toxicity reported to the u. K. National Poisons Information Service, Emergency Medicine Journal, 28, 686-689.
23. Johnson, P. S., Johnson, M. W. (2014) Investigation of "bath salts" use patterns within an online sample of users in the united States, Journal on Psychoactive Drugs, 46, 369-378.
24. Kidawa, M. (2011). What can prevalence data tell us? "Legal highs" in Poland. Presentation at First International Multidisciplinary Forum on New Drugs, 11-12.05.2011 Lisbon. (Website) www.politicheantidroga. it/media/ 467784/kidawa.pdf
25. Kikura-Hanajiri, R., uchiyama, N., Goda, Y. (2011). Survey of current trends in the abuse of psychotropic substances and plants in Japan, Legal Medicine, 13(3), 109-115.
26. King, L. a., Van Der Meer-Poortman, a. J. (2001). New synthetic drugs in the European union. Science & Justice, 41, 200-202.
27. Lapoint, J., James, L. P., Moran, C. L., Nelson, L. S., Hoffman, R. S., Moran, J. H. (2011). Severe toxicity following synthetic cannabinoid ingestion. Clinical Pharmacology (Philadelphia), 49, 760-764.
28. Lindigkeit, R., boehme, a., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., beuerle, T. (2009). Spice: A never ending story? Forensic Science International, 191, 58-63.
29. Lusthof, K. J., Oosting, R., Maes, a., Verschraagen, M., Dijkhuizen, a., Sprong, a. G. a. (2011) a case of extreme agitation and death after the use of mephedrone in The Netherlands, Forensic Science International, 206, 93-95.
30. Maskell, P. D, De Paoli, G., Seneviratne, C., Pounder, D. J. (2011). Mephedrone (4-methylmethcathinone) - related deaths, Journal of Analytical Toxicology, 35, 188-191.
31. Meyers, K., Kaynak, Ö., bresani, E., Curtis, b., McNamara, a., brownfield, K., Kirby, K. C. (2015). The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases? International Journal of Drug Policy. DOI: 10.1016/j.drugpo.2015.01.012.
32. Nichols, D. (2011). Legal highs: the dark side of medicinal chemistry, Nature, 469, 7.
33. Ramsey, J., Dargan, P. I., Smyllie, M., Davies, S., button, J., Holt, D. W., Wood, D. M. (2010). buying "legal" recreational drugs does not mean that you are not breaking the law. Quarterly Journal of Medicine, 103, 777-783.
34. Sainsbury, P. D., Kicman, a. T., archer, R. P., King, L. a. braithwaite, R. a. (2011). aminoindanes - the next wave of "legal highs"? Drug Testing and Analysis, 3, 479-482.
35. Schep, L. J., Slaughter, R. J., Vale, J. a., beasley, D. M. G., Gee, P. (2011). The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine, Clinical Toxicology, 49, 131-141.
36. Schifano, F., albanese, a., Fergus, S., Stair, J. L., Deluca, P., Corazza, O. (2011). Mephedrone (4-methylmethcathinone; "meow meow"): chemical, pharmacological and clinical issues, Psychopharmacology, 214, 593-602.
37. Schmidt, M. M., Sharma, a., Schifano, F., Feinmann, C. (2011). "Legal highs" on the net - Evaluation of uKbased Websites, products and product information. Forensic Science International, 206, 92-97.
38. Sedefov, R. (2011). Identification of new drugs and trends - from a European perspective. (Website) http:// drogenbeauftragte.de/fileadmin/dateien-dba/Drogenund- Sucht/Illegale-Drogen/Heroin-andere/Downloads/Sedefov. pdf
39. Showalter, V. M., Compton, D. R., Martin, b. R., abood, M. E. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (Cb2): identification of cannabinoid receptor subtype selective ligands. Journal of Pharmacology and Experimental Therapeutics, 278, 3, 989-999.
40. Smith, C. D., Robert, S. (2014). Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting. Clinical Medicine, 14, 409-415.
41. Winstock, a., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M., Marsden, J. (2011). Mephedrone: use, subjective effects and health risks. Addiction, 106, 1991-1996.
42. Wood, D. M., Davies, S., Smith, G., button, J., Ramsey, J., Holt, D. W. (2010). analytical findings of systematically purchased "legal highs" from the Internet. Toxicology Letters, 196, S296.
43. Zuba, D., byrska, b., Maciow, M. (2011) Comparison of "herbal highs" composition. Analytical and Bioanalytical Chemistry, 400, 119-126.